Involvement of AMPA/kainate and GABA A receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus

European Journal of Pharmacology

Volumn 784, Issue , 2016, Pages 181-191

  Motaghinejad, Majid ^a   Motevalian, Manijeh ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methylphenidate; Oxidative stress and inflammation; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 1BETA; KAINIC ACID RECEPTOR; METHYLPHENIDATE; SUPEROXIDE DISMUTASE; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA; FRUCTOSE; GLUTATHIONE DISULFIDE; GLUTATHIONE OXIDASE; LIGAND GATED ION CHANNEL; NEUROPROTECTIVE AGENT; OXIDOREDUCTASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BRAIN MITOCHONDRION; CELL LEVEL; CELL VACUOLE; CONTROLLED STUDY; DRUG MECHANISM; ENCEPHALITIS; ENZYME ACTIVITY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFECT; FEMALE; INFLAMMATION; METABOLISM; MITOCHONDRION;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; GLUTATHIONE DISULFIDE; HIPPOCAMPUS; INFLAMMATION; LIGAND-GATED ION CHANNELS; LIPID PEROXIDATION; MALE; METHYLPHENIDATE; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RECEPTORS, AMPA; RECEPTORS, GABA-A; RECEPTORS, KAINIC ACID; SUBSTANCE-RELATED DISORDERS; SUPEROXIDE DISMUTASE; TOPIRAMATE;

EID: 84971250036     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.04.036     Document Type: Article

References (67)

1. N.B. Agarwal, N.K. Agarwal, P.K. Mediratta, and K.K. Sharma Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice Seizure 20 2011 257 262
2. A.C. Andreazza, B.N. Frey, S.S. Valvassori, C. Zanotto, K.M. Gomes, C.M. Comim, C. Cassini, L. Stertz, L.C. Ribeiro, and J. Quevedo DNA damage in rats after treatment with methylphenidate Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 2007 1282 1288
3. A. Armaǧan, S. Kutluhan, M. YIlmaz, N. YIlmaz, M. Bülbül, H. Vural, S. Soyupek, and M. NazIroǧlu Topiramate and vitamin E modulate antioxidant enzyme activities, nitric oxide and lipid peroxidation levels in pentylenetetrazol-induced nephrotoxicity in rats Basic Clin. Pharmacol. Toxicol. 103 2008 166 170
4. D. Arnone Review of the use of topiramate for treatment of psychiatric disorders Ann. Gen. Psychiatry 4 2005 5 8
5. A. Bal-Price, and G.C. Brown Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity J. Neurosci. 21 2001 6480 6491
6. V. Bashkatova, V. Narkevich, G. Vitskova, and A. Vanin The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 487 492
7. J.-H. Cabungcal, D. Nicolas, R. Kraftsik, M. Cuénod, K.Q. Do, and J.-P. Hornung Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia Neurobiol. Dis. 22 2006 624 637
8. N. Cardenas-Rodriguez, E. Coballase-Urrutia, B. Huerta-Gertrudis, M. García-Cruz, J. Pedraza-Chaverri, R. Coria-Jiménez, C. Bandala, and M. Ruíz-García Antioxidant activity of topiramate: an antiepileptic agent Neurol. Sci. 34 2013 741 747
9. Challman, T.D., Lipsky, J.J., 2000. Methylphenidate: its pharmacology and uses, Mayo Clinic Proceedings, Elsevier, pp. 711-721.
10. J. Cheng, Z. Xiong, L.J. Duffney, J. Wei, A. Liu, S. Liu, G.-J. Chen, and Z. Yan Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors Biol. Psychiatry 76 2014 953 962
11. X. Cheng, and M. Li Effect of topiramate on apoptosis-related protein expression of hippocampus in model rats with Alzheimers disease Eur. Rev. Med Pharm. Sci. 18 2014 761 768
12. K. Chengappa, S. Gershon, and J. Levine The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder Bipolar Disord. 3 2001 215 232
13. A.M. Clark, J.T. Mondick, J.C. Cloyd, A.F. Zuppa, Y.H. Raol, and R.R. Clancy Plasma topiramate concentrations resulting from doses associated with neuroprotection against white matter injury and stroke in two strains of rat pups Pediatr. Res. 73 2012 317 324
14. C.M. Claussen, and N. Dafny Acute administration of methylphenidate alters the prefrontal cortex neuronal activity in a dose-response characteristic J. Exp. Pharmacol. 6 2014 1 9
15. C. Costa, G. Leone, E. Saulle, F. Pisani, G. Bernardi, and P. Calabresi Coactivation of GABAA and GABAB receptor results in neuroprotection during in vitro ischemia Stroke 35 2004 596 600
16. M. Cure, E. Cure, L. Tumkaya, Y. Kalkan, I. Aydin, A. Kirbas, H. Efe, I. Sehitoglu, and S. Yuce Topiramate has protective effect on renal injury Bratisl. lek. listy 116 2014 259 263
17. I. dela Pena, J.C. Lee, H.L. Lee, T.S. Woo, H.C. Lee, A.R. Sohn, and J.H. Cheong Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment Neurosci. Lett. 514 2012 189 193
18. S. Demirci, S. Kutluhan, M. NazIroǧlu, A.C. Uǧuz, V.A. Yürekli, and K. Demirci Effects of selenium and topiramate on cytosolic Ca2+ influx and oxidative stress in neuronal PC12 cells Neurochem. Res. 38 2013 90 97
19. Dudley, J.T., Sirota, M., Shenoy, M., Pai, R.K., Roedder, S., Chiang, A.P., Morgan, A.A., Sarwal, M.M., Pasricha, P.J., Butte, A.J., 2011. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Science Translational Medicine, vol. 3, 96ra76-96ra76.
20. P.L. Follett, W. Deng, W. Dai, D.M. Talos, L.J. Massillon, P.A. Rosenberg, J.J. Volpe, and F.E. Jensen Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate J. Neurosci. 24 2004 4412 4420
21. L. Freese, E. Muller, M. Souza, N. Couto-Pereira, C. Tosca, M. Ferigolo, and H. Barros GABA system changes in methylphenidate sensitized female rats Behav. Brain Res. 231 2012 181 186
22. B.N. Frey, M.R. Martins, F.C. Petronilho, F. Dal-Pizzol, J. Quevedo, and F. Kapczinski Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania Bipolar Disord. 8 2006 275 280
23. B.N. Frey, S.S. Valvassori, K.M. Gomes, M.R. Martins, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure Brain Res. 1097 2006 224 229
24. W.R. Garnett Clinical pharmacology of topiramate: a review Epilepsia 41 2000 61 65
25. D.S. Gryder, and M.A. Rogawski Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons J. Neurosci. 23 2003 7069 7074
26. C. Heidbreder Novel pharmacotherapeutic targets for the management of drug addiction Eur. J. Pharmacol. 526 2005 101 112
27. P. Holland, S. Akerman, and P. Goadsby Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors Cephalalgia 30 2010 519 527
28. M. Huss, and U. Lehmkuhl Methylphenidate and substance abuse: a review of pharmacology Anim., Clin. Stud. J. Atten. Disord. 6 2001 S65 S71
29. S. Izenwasser, A.E. Coy, B. Ladenheim, R.J. Loeloff, J.L. Cadet, and D. French Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine Eur. J. Pharmacol. 373 1999 187 193
30. A. Klejman, M. Wȩgrzynowicz, E.M. Szatmari, B. Mioduszewska, M. Hetman, and J. Albrecht Mechanisms of ammonia-induced cell death in rat cortical neurons: roles of NMDA receptors and glutathione Neurochem. Int. 47 2005 51 57
31. A. Koçer, R. Memişoǧullari, F.M. Domaç, A. Ilhan, E. Koçer, Ş. Okuyucu, B. Özdemir, and H. Yüksel IL-6 levels in migraine patients receiving topiramate Pain Pract. 9 2009 375 379
32. M. Kuloglu, B. Ustundag, M. Atmaca, H. Canatan, A.E. Tezcan, and N. Cinkilinc Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder Cell Biochem. Funct. 20 2002 171 175
33. S. Kutluhan, M. NazIroǧlu, Ö. Çelik, and M. YIlmaz Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats Biol. Trace Elem. Res. 129 2009 181 189
34. P.R. Louzada, A.C.P. Lima, D.L. Mendonça-Silva, F. Noël, F.G. De Mello, and S.T. Ferreira Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders FASEB J. 18 2004 511 518
35. X. Mao, C. Ji, C. Sun, D. Cao, P. Ma, Z. Ji, F. Cao, D. Min, S. Li, and J. Cai Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis Neurochem. Int. 60 2012 39 46
36. A.L. Marriott, R.A. Tasker, C.L. Ryan, and T.A. Doucette Alterations to prepulse inhibition magnitude and latency in adult rats following neonatal treatment with domoic acid and social isolation rearing Behav. Brain Res. 298 2016 310 317
37. M.R. Martins, A. Reinke, F.C. Petronilho, K.M. Gomes, F. Dal-Pizzol, and J. Quevedo Methylphenidate treatment induces oxidative stress in young rat brain Brain Res. 1078 2006 189 197
38. J.-F. Mathieu, A. Ferron, K.M. Dewar, and T.A. Reader Acute and chronic effects of methylphenidate on cortical adrenoceptors in the rat Eur. J. Pharmacol. 162 1989 173 178
39. M. Motaghinejad, M. Karimian, O. Motaghinejad, B. Shabab, I. Yazdani, and S. Fatima Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus Pharmacol. Rep. 67 2015 230 235
40. M. Motaghinejad, S.M. Karimian, O. Motaghinejad, B. Shabab, M. Asadighaleni, and S. Fatima The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats Fundam. Clin. Pharmacol. 29 2015 299 309
41. M. Motaghinejad, M. Motevalian, and A. Ebrahimzadeh Reduction of methylphenidate induced anxiety, depression and cognition impairment by various doses of venlafaxine in rat Int. J. Prev. Med. 6 2015 52 59
42. M. Motaghinejad, M. Motevalian, S.F. Larijani, and Z. Khajehamedi Protective effects of forced exercise against methylphenidate-induced anxiety, depression and cognition impairment in rat Adv. Biomed. Res. 4 2015 134 138
43. Motaghinejad, M., Motevalian, M., Shabab, B., 2015e. Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Neurosci. Lett. [Epub ahead of print].
44. M. Motaghinejad, M. Motevalian, and B. Shabab Neuroprotective effects of various doses of topiramate against methylphenidate induced oxidative stress and inflammation in rat isolated hippocampus Clin. Exp. Pharmacol. Physiol. 43 2015 360 371
45. M. NazIroǧlu, and V.A. Yürekli Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements Cell. Mol. Neurobiol. 33 2013 589 599
46. C. Nopparat, J.E. Porter, M. Ebadi, and P. Govitrapong The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy J. Pineal Res. 49 2010 382 389
47. T.O. Price, V. Eranki, W.A. Banks, N. Ercal, and G.N. Shah Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice Endocrinology 153 2011 362 372
48. T.O. Price, S.A. Farr, M.L. Niehoff, N. Ercal, J.E. Morley, and G.N. Shah Protective effect of topiramate on hyperglycemia-induced cerebral oxidative stress, pericyte loss and learning behavior in diabetic mice Int. Libr. Diabetes Metab. 1 2015 6 12
49. B. Prieto-Gomez, A. Vazquez-Alvarez, J. Martinez-Pena, C. Reyes-Vazquez, P. Yang, and N. Dafny Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area Life Sci. 77 2005 635 649
50. R.B. Raffa, K.E. Finno, C.S. Tallarida, and S.M. Rawls Topiramate-antagonism of L-glutamate-induced paroxysms in planarians Eur. J. Pharmacol. 649 2010 150 153
51. G.Z. Réus, G. Scaini, G.C. Jeremias, C.B. Furlanetto, M.O. Morais, L.M. Mello-Santos, J. Quevedo, and E.L. Streck Brain apoptosis signaling pathways are regulated by methylphenidate treatment in young and adult rats Brain Res. 1583 2014 269 276
52. G.Z. Réus, G. Scaini, S.E. Titus, C.B. Furlanetto, L.B. Wessler, G.K. Ferreira, C.L. Gonçalves, G.C. Jeremias, J. Quevedo, and E.L. Streck Methylphenidate increases glucose uptake in the brain of young and adult rats Pharmacol. Rep. 67 2015 1033 1040
53. C. Rozas, C. Carvallo, D. Contreras, M. Carreño, G. Ugarte, R. Delgado, M. Zeise, and B. Morales Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors Neuropharmacology 99 2015 15 27
54. A.T. Schaefers, G. Teuchert-Noodt, F. Bagorda, and S. Brummelte Effect of postnatal methamphetamine trauma and adolescent methylphenidate treatment on adult hippocampal neurogenesis in gerbils Eur. J. Pharmacol. 616 2009 86 90
55. M. Schwarz, K. Jandová, I. Struk, D. Maresova, J. Pokorný, and V. Riljak Low dose domoic acid influences spontaneous behavior in adult rats Physiol. Res. 63 2014 369 376
56. A.N. Shafik Effects of topiramate on diabetes mellitus induced by streptozotocin in rats Eur. J. Pharmacol. 684 2012 161 167
57. R.P. Shank, J.F. Gardocki, A.J. Streeter, and B.E. Maryanoff An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action Epilepsia 41 2000 3 9
58. W. Sobaniec, E. Solowiej, W. Kulak, L. Bockowski, J. Smigielska-Kuzia, and B. Artemowicz Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsy J. Child Neurol. 21 2006 558 562
59. P.K. Sonsalla, D.E. Riordan, and R.E. Heikkila Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice J. Pharmacol. Exp. Ther. 256 1991 506 512
60. H. Tagaya [(Methylphenidate: pharmacology, indication and potential of abuse). Nihon rinsho Jpn. J. Clin. Med. 68 2010 1550 1555
61. Y. Tian, S.-X. Guo, J.-R. Li, H.-G. Du, C.-H. Wang, J.-M. Zhang, and Q. Wu Topiramate attenuates early brain injury following subarachnoid haemorrhage in rats via duplex protection against inflammation and neuronal cell death Brain Res. 1622 2015 174 185
62. K. van der Marel, V. Bouet, G. Meerhoff, T. Freret, M. Boulouard, F. Dauphin, A. Klomp, P. Lucassen, J. Homberg, and R. Dijkhuizen Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis Neuroscience 309 2015 243 258
63. 2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration Trends Neurosci. 23 2000 365 371
64. H.S. White Molecular pharmacology of topiramate: managing seizures and preventing migraine Headache: J. Head Face Pain 45 2005 S48 S56
65. V.A. Yürekli, and M. NazIroǧlu Selenium and topiramate attenuates blood oxidative toxicity in patients with Epilepsy: A Clinical Pilot Study Biol. Trace Elem. Res. 152 2013 180 186
66. Zare, S., Farrokhi, F., 2014. The Effect of Oral Administration of Methylphenidate on Hippocampal Tissue in Adult Male Rats. Neurosurg. Q.
67. Q. Zhu, Y. Sun, J. Zhu, T. Fang, W. Zhang, and J.-X. Li Antinociceptive effects of sinomenine in a rat model of neuropathic pain Sci. Rep. 4 2014 7270 7279